Maureen Sartor, PhD
Manage Your Profile
Center Memberships
-
Center MemberRogel Cancer Center
-
Center MemberAI and Digital Health Innovation
Research Overview
The Sartor laboratory has both methodological and biomedical areas of focus. Their methodological focus is bioinformatics methods and tools for the analysis of genome-wide regulatory and epigenomics data, and for assessing the biological/clinical significance of results. For instance, Dr. Sartor is a member of the Impact of Genomic Variants on Function (IGVF) NIH Consortium, for which she is developing a coupled tensor-matrix completion method to prioritize disease-specific variant-gene target pairs. The Sartor Lab also focuses on multi-omics approaches for biomarker and treatment-target discovery in disease, focusing specifically on Amyotrophic Lateral Sclerosis (ALS) and head and neck squamous cell carcinomas (HNSCC). Dr. Sartor is PI of an R01 studying downstream consequences of HPV integration in HPV-associated HNSCC, and Co-PI of a Transformative R01 linking environmental exposures with multi-omics in ALS. Being formally trained in biostatistics, Dr. Sartor uses machine learning and statistical approaches to make advances in the above areas.
Links
Sartor Lab
Recent Publications
-
Lawas MM, Hsieh M, Patil S, Mohebbi E, Zhang R, Ahn J, Benjamin W, Chinn SB, Witek M, Mabvakure B, Duttargi A, Cruz LM, Garb B, Li S, D'Silva NJ, Sartor MA, Rozek LS. Neoplasia, 2026 Jul 2; 79: 101323Journal ArticleThe importance of HPV testing in oropharyngeal cancer in two US populations.
DOI:10.1016/j.neo.2026.101323 PMID: 42391786 -
Purrington K, Hsieh M-C, Patil S, Mabvakure B, Ahn J, Zhang R, Ruterbusch JJ, Samdani R, Lee G, Wenzlaff A, Latif S, Dash C, Sartor M, Schwartz AG, Stoffel EM, Rozek LS. 2026 Jun 29;PreprintRace and Socioeconomic Status Impact Survival from Early and Late-Onset Colorectal Cancer.
DOI:10.64898/2026.06.24.26356439 PMID: 42428080 -
Mabvakure BM, Promprasert P, Martinez Cruz L, Patil S, Barros J, Hayhurst M, Mohebbi E, de la Caridad Delgado Herrera D, Lee G, Latif S, Williams F, Samdani R, Duttargi A, Berhane B, Besufikad E, Tadesse S, Jibril Suleiman A, Lefante C, Hsieh M-C, Purrington K, Adjei E, Qin T, Sartor M, Stoffel EM, Rozek LS. 2026 Jun 29;PreprintSomatic Mutation Profiles in Colorectal Cancers Differ by Population.
DOI:10.64898/2026.06.24.26356431 PMID: 42428056 -
Chen X-W, Wang H, Bajaj K, Zhang P, Ma D, Bai Y, Liu H-H, Adams E, Baines A, Yu G, Sartor MA, Zhang B, Yi Z, Lin J, Young SG, Schekman R, Ginsburg D. Elife, 2026 Jun 24; 15:Journal ArticleCorrection: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.
DOI:10.7554/eLife.112375 PMID: 42339786 -
Xia S, Lim YX, Liu M, Grab B, Patil S, Li S, Rozek L, D'silva NJ, Sartor MA. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 3943 - 3943.Journal ArticleAbstract 3943: Morphology-derived spindle-cell gene signature in HPV+ HNSCC is linked to pEMT, molecular subtype, HPV integration, and recurrence-free survival.
DOI:10.1158/1538-7445.am2026-3943 -
Zhang Y, Ntsiful DA, Israel R, Vandenburg B, Barnett S, Riethoven J-J, Clarke J, Lagisetty K, Lin J, Reddy RM, Chang A, Odell D, DiFeo A, Sartor MA, Kresty LA. Cell Death and Disease, 2025 May 29;Journal ArticleIdentification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets, In Revision
-
Li S, Chou E, Wang K, Boyle AP, Sartor MA. 2026 Mar 8; bioRxiv,PreprintTFBSpedia: a comprehensive human and mouse transcription factor binding sites database
DOI:10.64898/2026.03.04.709638 -
Li S, Xia S, Lawas M, Kulshreshtha A, Garb BF, Soppe SE, Perera C, Li C, Liu M, Lim YX, Qin T, Welch JD, D’silva NJ, Rozek LS, Sartor MA. Clinical Cancer Research, 2026 Feb 1; 32 (3): 581 - 595.Journal ArticleHPV Integration in Head and Neck Cancer: Downstream Splicing Events and Expression Ratios Linked with Poor Outcomes
DOI:10.1158/1078-0432.CCR-25-0645 PMID: 41269209
Featured News & Stories
Elysia Chou receives Rackham Predoctoral Fellowship
Researchers develop models to help diagnose ALS earlier through blood biomarkers